Assessing Impact of CCO's PSO & PC Pathway in Ambulatory HNC Clinics

NACompletedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

October 10, 2017

Primary Completion Date

November 29, 2019

Study Completion Date

December 3, 2019

Conditions
Head and Neck CancerSupportive Care
Interventions
OTHER

PSOPC pathway approach

"The intervention will use a standardized PSOPC pathway approach, prompted follow up with patients and documentation.~Additionally, clinicians will be prompted to document conversations about response to emotional or physical ESAS symptom scores, symptom management plan (self/education/monitoring/medication), illness understanding; and, if necessary, an offer of PSO/PC referral."

Trial Locations (1)

M4N3M5

Sunnybrook Health Sciences Centre, Toronto

All Listed Sponsors
lead

Sunnybrook Health Sciences Centre

OTHER

NCT03266276 - Assessing Impact of CCO's PSO & PC Pathway in Ambulatory HNC Clinics | Biotech Hunter | Biotech Hunter